Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
news
What
company
3
×
device
3
×
market
3
×
medical
developing
new
according
amaranth
apple
apple’s
aptitude
better
bioresorbable
called
campaign
cardiology
ceo
change
clearance
cleared
clinical
commercial
company's
crowdfunding
cur
depth
determined
dispute
doing
doom
eluting
end
far
fast
fda
fight
filing
follow
generation
goes
Language
unset
Current search:
company
×
market
×
device
×
@9to5mac.com
4 months ago
Masimo CEO on why he’s spending over $100 million to fight Apple: ‘It might change Apple for the better’
@venturebeat.com
7 years ago
Amaranth Medical Provides Clinical and Commercial Update on 115-micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
@theverge.com
9 years ago
Cur is crowdfunding a medical device that isn't cleared by the FDA, and that's a problem